HealthEquity Analyst Price Targets - Benzinga

HealthEquity Inc

HQYNASDAQ

Trade with Public

Trade with Public

$92.61

-0.44-0.47%

Últ. Act.: Oct 9, 4:00 PM

$92.61

-0.44-0.47%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

HealthEquity Analyst Price Targets - Benzinga

HealthEquity Analyst Price Targets

Wall Street analyst price targets and consensus rating for HealthEquity (HQY).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

3S.Buy

13Buy

1Sell

Consensus RatingOutperform# Analysts17Avg. Consensus PT$115Upside to Avg. PT+24.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 18, 2026	Barclays	Peter Warendorf	PT Raise	Overweight	$110→$115
Aug 31, 2026	Deutsche Bank	George Hill	PT Raise	Buy	$135→$142
Aug 28, 2026	BTIG	David Larsen	Maintained	Buy	$115
Jul 24, 2026	BTIG	David Larsen	PT Raise	Buy	$110→$115
Jun 3, 2026	RBC Capital	Ryan Halsted	Maintained	Outperform	$108
Jun 1, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$110→$111
May 29, 2026	RBC Capital	Ryan Halsted	PT Raise	Outperform	$100→$108
May 22, 2026	Barrington Research	Alexander Paris	Maintained	Outperform	$110
Apr 9, 2026	BMO Capital	Sean Dodge	Upgrade	Market Perform→Outperform	$85→$105
Mar 19, 2026	Deutsche Bank	George Hill	PT Raise	Buy	$120→$128
Mar 18, 2026	Barrington Research	Alexander Paris	PT Cut	Outperform	$125→$110
Mar 18, 2026	JP Morgan	Alexei Gogolev	PT Cut	Overweight	$129→$123
Mar 18, 2026	RBC Capital	Daniel R. Perlin	PT Cut	Outperform	$110→$100
Feb 18, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$118→$110
Feb 17, 2026	BTIG	David Larsen	PT Cut	Buy	$130→$110
Jan 9, 2026	Goldman Sachs	David Roman	Downgrade	Neutral→Sell	$89
Jan 8, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$120→$125
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Overweight	$118
Dec 4, 2025	Barrington Research	Alexander Paris	Maintained	Outperform	$125
Dec 4, 2025	JP Morgan	Alexei Gogolev	PT Raise	Overweight	$126→$129

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115

Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.

Benzinga Newsdesk

PRO
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $135 to $142.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $115 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $110 to $115.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

RBC Capital analyst Ryan Halsted reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maintains $108 price target.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on HealthEquity, Raises Price Target to $111

Citizens analyst Constantine Davides maintains HealthEquity (NASDAQ:HQY) with a Market Outperform and raises the price target from $110 to $111.

Benzinga Newsdesk